Also known as Maxalt
Rizatriptan (trade name Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).Source: Wikipedia
DEA Class 5 meaning lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.
Estimated Total Cost: $261.83 for an average of 21 days supply
Patients are most commonly prescribed rizatriptan to treat migraine, headache, tension headache, and restless leg syndrome.